Bioclone（澳大利亞）是Hitachi化學公司在澳大利亞的子公司, 專門經(jīng)營高品質(zhì)免疫診斷試劑的生產(chǎn)與銷售。該公司成立于1981年，在1997年6月經(jīng)過重新部署，主要生產(chǎn)臨床和實驗室用的免疫診斷產(chǎn)品。公司已通過ISO9001:2000質(zhì)量管理體系認證，其診斷設(shè)備獲得澳洲國家藥品管理局TGA認證，產(chǎn)品均具有CE標志。

公司產(chǎn)品主要有：

酶標測定（ELISA）

衣原體抗體測定（Chlamydia Antibody Tests）

妊娠與生育測定（Pregnancy / Fertility Tests）

生長素，甲狀腺素及其他測定（Growth, Thyroid, Other Tests）

篩選測定（Screening Tests）

免疫放射定量檢測 （Immunoradiometric assay，IRMA）

放射性免疫測定（Radioimmunoassay，RIA）

過敏檢測（Allergen）

抗體（Antibodies）

單克隆抗體（Monoclonal Antibodies）

多克隆抗體（Polyclonal Antibodies）

 Bioclone Australia Pty. Limited is an Australian-based subsidiary of Hitachi Chemical Co., Ltd., specialising in the design and manufacture of high quality immunodiagnostic products for medical and research laboratory markets globally. Associated contract services are also provided by Bioclone.

Bioclone is an Australian-based subsidiary of Hitachi Chemical Co., Ltd., specialising in the manufacture of high quality immunodiagnostic products for the medical and research laboratory markets.

Bioclone was formed in 1981 to take advantage of Australian expertise in medical research and biotechnology. A collaborative project between the CSIRO and the Garvan Institute for Medical Research gave Bioclone an excellent range of monoclonal antibodies to pituitary hormones from which diagnostic kits were later developed.

Bioclone now produces Australia's largest range of immunoassay products for the medical diagnostics market. The products are marketed worldwide through a network of distributors.

Bioclone has continued to invest in innovation and new product development both through collaboration with research organisations and through its own Research and Development team.

The facility operates under the Quality Management System umbrella of ISO9001:2000 and is TGA certified for diagnostic manufacture. The Bioclone product range also carries the CE Mark.